Results 101 to 110 of about 940,251 (149)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease

open access: yes
Gaucher Disease (GD) is an autosomal recessive, lysosomal storage disease caused by pathogenic variants in the glucocerebrosidase gene, leading to the loss of β-glucocerebrosidase (GCase) enzymatic activity.
Wilson Lau Junior   +26 more
core   +2 more sources

β-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters. [PDF]

open access: yesNeurology, 2020
Huh YE   +19 more
europepmc   +1 more source

Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models. [PDF]

open access: yesJ Neuroinflammation
Brunialti E   +17 more
europepmc   +1 more source

Lewy Body–like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α‐Synuclein Mutations [PDF]

open access: yes
Objective We utilized human midbrain-like organoids (hMLOs) generated from human pluripotent stem cells carrying glucocerebrosidase gene (GBA1) and α-synuclein (α-syn; SNCA) perturbations to investigate genotype-to-phenotype relationships in Parkinson ...
Saw, Tzuen Yih   +19 more
core  

β-Glucocerebrosidase Modulators Promote Dimerization of β-Glucocerebrosidase and Reveal an Allosteric Binding Site. [PDF]

open access: yesJ Am Chem Soc, 2018
Zheng J   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy